1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT: OCTOBER 5, 2001

COLORADO MEDTECH, INC.
------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

<Table>

COLORADO 000-12471 84-0731006
---------------------------- --------- ---------------
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation) Number) Identification No.)
</Table>

6175 LONGBOW DRIVE
BOULDER, COLORADO 80301
-----------------------
(Address, including zip code, of principal executive offices)

(303) 530-2660
-------------------------------
(Registrant's telephone number,
including area code)

ITEM 7. FINANCIAL STATEMENT AND EXHIBITS.

No. Description

99.1 Investor and analyst presentation materials of the President
and Chief Executive Officer and the Chief Financial Officer of
Colorado MEDtech, Inc. to be used on October 8, 2001 and from
time to time thereafter.

ITEM 9. REGULATION FD DISCLOSURE

On October 8, 2001, Colorado MEDtech, Inc. management will meet with
investors and analysts. A copy of the presentation materials of the company's
President and Chief Executive Officer and Chief Financial Officer that will be
used at those meetings and which are to be used from time to time thereafter is
filed as Exhibit 99.1 hereto.

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

DATED, this 5th day of October, 2001.

COLORADO MEDTECH, INC.

By: /s/ Gregory A. Gould
----------------------------------
Gregory A. Gould
Chief Financial Officer

-3-

INDEX TO EXHIBITS

<Table>
<Caption>
EXHIBIT
NUMBER DESCRIPTION
------ -----------